胸腺基质淋巴细胞生成素
相扑蛋白
信使核糖核酸
生物
转录因子
泛素
炎症
抄写(语言学)
过敏性炎症
免疫学
泛素连接酶
细胞生物学
基因
遗传学
语言学
哲学
作者
Shixiu Liang,Zicong Zhou,Changhui Yu,Zili Zhou,Jieyi Liu,Wufeng Huang,Hangming Dong,Fei Zou,Haijin Zhao,Shaoxi Cai
标识
DOI:10.1165/rcmb.2021-0301oc
摘要
Thymic stromal lymphopoietin presents in two distinct isoforms: short-form (sfTSLP) and long-form (lfTSLP). lfTSLP promotes inflammation, whereas sfTSLP inhibits inflammation, in allergic asthma. However, little is known about the regulation of lfTSLP and sfTSLP during allergic attack in the asthma airway epithelium. Here, we report that small ubiquitin-like modifier (SUMOylation) was enhanced in house dust mite-induced allergic asthma airway epithelium. Inhibition of SUMOylation significantly alleviated airway T-helper cell type 2 inflammation and lfTSLP expression. Mechanistically, chromobox 4 (CBX4), a SUMOylation E3 ligase, enhanced lfTSLP mRNA translation, but not sfTSLP, through the RNA-binding protein muscle excess (MEX)-3B. MEX-3B promoted lfTSLP translation by binding the lfTSLP mRNA through its K homology domains. Furthermore, CBX4 regulated MEX-3B transcription in human bronchial epithelial cells through enhancing SUMOylation concentrations of the transcription factor TFII-I. In conclusion, we demonstrate an important mechanism whereby CBX4 promotes MEX-3B transcription through enhancing TFII-I SUMOylation and MEX-3B enhances the expression of lfTSLP through binding to the lfTSLP mRNA and promoting its translation. Our findings uncover a novel target of CBX4 for therapeutic agents for lfTSLP-mediated asthma.
科研通智能强力驱动
Strongly Powered by AbleSci AI